Medistep Healthcare Limited (NSE:MEDISTEP)
India flag India · Delayed Price · Currency is INR
19.50
+0.30 (1.56%)
At close: Aug 4, 2026

Medistep Healthcare Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
708.31708.31496.55390.72276.4776.24
Revenue Growth
829.00%42.65%27.09%41.33%262.61%-
Gross Profit
90.0690.0660.9648.7915.215.71
Operating Income
82.4482.4455.6945.312.742.96
Net Income
59.8359.8341.4429.149.211.9
Earnings Per Share
4.684.684.0119.96--
EPS Growth
-16.74%-79.92%---

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022
Period EndingMar '25 Mar '24 Mar '23 Mar '22
Manufacturing
131.62---
Trading
364.9374.57276.4776.24
Total
496.5574.57276.4776.24

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
6.136.1313.10.11.240.31
Total Debt
51.8151.816.353.265.3210.57
Net Cash (Debt)
-45.68-45.686.75-3.16-4.08-10.26
Net Cash Growth
------
Net Cash Per Share
-3.57-3.570.65-2.17--

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-194.77-194.770.22-69.634.42-
Capital Expenditures
-0.09-0.09--1.52--
Free Cash Flow
-194.87-194.870.22-71.154.42-
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
12.71%12.71%12.28%12.49%5.50%7.49%
Operating Margin
11.64%11.64%11.21%11.59%4.61%3.88%
Pretax Margin
11.29%11.29%11.15%11.38%4.45%3.32%
Profit Margin
8.45%8.45%8.35%7.46%3.33%2.49%
FCF Margin
-27.51%-27.51%0.04%-18.21%1.60%-

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
4.173.92----
PS Ratio
0.390.33----